Skip to main content
OpenTrials
Completed

NCT Number: NCT05716997

Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty

The goal of this prospective observational study is to learn about in patients who need percutaneous coronary intervention for coronary artery disease. The main questions it aims to answer are:

* Fractional flow reserve according to coronary angiography findings after coronary artery balloon angioplasty * Differences in fractional blood flow reserve before and after lesions between coronary balloon angioplasty using a scoring balloon and a regular balloon Participants will voluntarily consent to the study after being fully informed about the study and given ample opportunity to ask questions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ewha Womans University Mokdong Hospital, Seoul, South Korea

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with clinically stable coronary artery disease
  • Patients undergoing balloon angioplasty as an interventional procedure (FFR-guided PCI) using coronary artery fractional blood flow reserve for de novo lesions with a standard vessel diameter of 2.25 mm or more under percutaneous coronary angiography (hereafter referred to as coronary angiography)

(Note) If there are other lesions in the proximal area and the FFR of the distal lesion is collected, it is included in the selection target regardless of whether or not the proximal lesion was operated on.

Exclusion criteria

  • Target lesion with stenosis of less than 50% or greater than 90% of the internal diameter
  • Procedure for restenosis within the stent
  • Pre-dilation performed on the target lesion before the coronary artery fractional blood flow reserve test
  • Prior coronary artery bypass surgery
  • Clinically unstable or ST-segment elevation myocardial infarction
  • Myocardial infarction in the region supplied by the target vessel
  • Target vessel is a blood vessel that supplies collateral circulation for occlusion of other blood vessels (not applicable when the need for collateral circulation has been resolved due to the opening of another vessel occlusion)
  • Left ventricular ejection fraction (EF) less than 30%
  • Most recently measured eGFR is less than 30 right before the procedure
  • Accompanying primary valve disease requiring treatment
  • Accompanying primary heart disease such as dilated cardiomyopathy, hypertrophic cardiomyopathy, or restrictive cardiomyopathy
  • Congenital heart disease

Treatment and study plan

Primary outcomes

  1. Differences in fractional flow reserve (FFR) according to angiographic findings after coronary artery balloon angioplasty

    Time frame: 15 minutes

    Coronary angiographic findings and fractional flow within 15 minutes after coronary balloon angioplasty are collected and analyzed.

Secondary outcomes

  1. Comparison of differences in fractional flow reserve (FFR) before and after lesions between coronary balloon angioplasty using a scoring balloon and a regular balloon

    Time frame: 1 year

    Determine whether a scoring balloon or a general balloon was used during balloon angioplasty, and analyze whether there is a difference in FFR depending on the balloon used.

  2. 1-year outcome

    Time frame: 1 year

    Relationship between major cardiac events within 1 year according to changes in pre- and post-lesional fractional flow reserve (FFR), steady-state pressure ratio, and quantitative flow analysis (QFR) values before and after coronary artery balloon angioplasty

  3. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific minimum lumen area

    Time frame: 1 year

    Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific minimum lumen area (mm2)

  4. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific plaque burden

    Time frame: 1 year

    Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific plaque burden (plaque burden = plaque cross-sectional area (CSA, mm2)+ media CSA / external elastic membrane CSA)

  5. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific positive remodeling

    Time frame: 1 year

    Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific positive remodeling (remodeling ratio > 1.05).

    remodeling ratio (RR) = external elastic membrane (EEM) area lesion/EEM area proximal reference

  6. Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific attenuated plaque

    Time frame: 1 year

    Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific attenuated plaque Attenuated Plaque: Plaque seen in intravascular ultrasound with acoustic shadowing behind large, echolucent acute culprit lesion sites, in the absence of bright calcium.

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Collaborators

  • Ewha Womans University Mokdong Hospital

Registry information

Official study title

A PRospective Observational Study on the Relationship BEtween Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty: PROBE-FFR

Acronym: PROBE-FFR

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
Feb 8, 2023
Registry last updated
Feb 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.